Friday, October 26, 2007
Sunday, October 14, 2007
October 12, 2007
In a shareholders meeting recently Reliance Industries Chairman, Mr. Mukesh Ambani proposed five shifts in the strategy of Reliance Industries in future, surprisingly one of the major one is, shift in innovation.
Traditionally, Reliance has grown on the strength of licensing technologies.
This strategy has limitations in its play in the context of technology-driven opportunities and global competitors harboring
So now India's biggest Petrochemical company becomes serious for owning IP in the line of Exxon Mobil and Shell.
Friday, October 12, 2007
Earlier this year, Pune-based Lupin Ltd. assigned its patent right (process patents) over antihypertensive drug perindopril to French company Laboratories Servier for 20 million euros, now further to the development Lupin has assigned additional patent rights for additional 20 million euros. Perindopril patent assignment is one of the significant commercial transactions made by an Indian company from its intellectual property portfolio.
Thursday, October 11, 2007
Thursday, October 04, 2007
Hoffmann-La-Roche has filed patent infringement lawsuits in the US District Court for the District of New Jersey to safeguard its patent rights over Boniva, generically ibandronate sodium against Indian generic drug manufacturers, Dr. Reddy’s Laboratories Ltd. and Orchid Chemicals and Pharmaceuticals Ltd., both filed Abbreviated New Drug Application (ANDA) with the United States Food and Drug Administration seeking regulatory approval to market generic ibandronate before expiration of two Orange Book US Patent Nos. 7,192,938 (the ‘938 patent), expiring May 06, 2023, and 6,294,196 (the ‘196 patent), expiring October 07, 2019. However, Dr. Reddy’s has made Paragraph IV certification against the ‘196 patent, not the ‘938 patent. HLR also filed infringement complaints against Cobalt alleging infringement of four Orange Book US Patent Nos. ‘938 patent, ‘196 patent, 6,143,326 (the ‘326 patent), and 4,927,814 (the ‘814 patent).